Alnylam Pharmaceuticals
ALNY
#734
Rank
A$48.69 B
Marketcap
A$363.91
Share price
-1.90%
Change (1 day)
-46.72%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company